HYPEREOSINOPHILIC SYNDROME IN A MYELOPROLIFERATIVE VARIETY - THERAPEUTIC SUCCESS AFTER AN 18-MONTH TREATMENT WITH INTERFERON-ALPHA

被引：0
|
作者：
DINE, G
NAJMAN, A
BRAHIMI, S
CULIOLI, B
ABID, A
DUPOIRIEUX, J
机构：
[1] HOP HAUTS CLOS,SERV MALAD SANG,F-10003 TROYES,FRANCE
[2] HOP ST ANTOINE,SERV,MALAD SANG,F-75571 PARIS 12,FRANCE
来源：
PRESSE MEDICALE | 1992年 / 21卷 / 37期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1776 / 1776
页数：1
相关论文
共 50 条
  • [31] INCREASED INTERFERON-ALPHA SIGNALING DURING MEGAKARYOCYTE ONTOGENY: IMPLICATIONS FOR THE SPONTANEOUS RESOLUTION OF DOWN SYNDROME TRANSIENT MYELOPROLIFERATIVE DISORDER
    Cantor, Alan
    Woo, Andrew
    Akie, Thomas
    Karen, Wieland
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 795 - 795
  • [32] A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome
    Metzler, C.
    Schnabel, A.
    Gross, W. L.
    Hellmich, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (03) : S35 - S40
  • [33] TREATMENT OF METASTATIC CARCINOID-TUMOR AND THE CARCINOID-SYNDROME WITH RECOMBINANT INTERFERON-ALPHA
    NIEDERLE, N
    MENGELKOCH, B
    DOBERAUER, C
    KLOKE, O
    WANDL, U
    TUMORDIAGNOSTIK & THERAPIE, 1994, 15 (05) : 192 - 196
  • [34] TREATMENT OF HAIRY-CELL LEUKEMIA WITH INTERFERON-ALPHA(IFN-ALPHA) - BEFORE OR AFTER SPLENECTOMY
    PORZSOLT, F
    DIGEL, W
    HEIL, G
    BARTRAM, CR
    RAGHAVACHAR, A
    KERN, W
    SEIFRIED, E
    RAGHAVACHAR, A
    HEIMPEL, H
    BLUT, 1986, 53 (03): : 213 - 213
  • [35] Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms
    Lindgren, Marie
    Samuelsson, Jan
    Nilsson, Lars
    Knutsen, Havar
    Ghanima, Waleed
    Westin, Johan
    Johansson, Peter L.
    Andreasson, Bjorn
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (05) : 419 - 425
  • [36] Islet-cell antibodies and type 1 diabetes after treatment with interferon-alpha
    Schories, M
    Peters, T
    Rasenack, J
    Reincke, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (20) : 1120 - 1124
  • [37] INTERFERON-ALPHA MAINTENANCE THERAPY AFTER CYTOTOXIC CHEMOTHERAPY FOR TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED KAPOSIS-SARCOMA
    GILL, PS
    RARICK, MU
    BERNSTEINSINGER, M
    ESPINA, BM
    JONES, B
    MONTGOMERY, T
    SHARMA, D
    RASHEED, S
    LEVINE, AM
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (05): : 512 - 516
  • [38] Interferon-alpha and ribavirin treatment in patients with Sjogren's syndrome associated with hepatitis C virus
    Ramos-Casals, M
    Loustaud-Ratti, V
    De Vita, S
    De Marchi, G
    Medina, F
    Anaya, J
    Font, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 534 - +
  • [39] Sick sinus syndrome associated with Erdheim-Chester disease was reversed by interferon-alpha treatment
    Guo, Xinli
    Xu, Yuanwei
    Wan, Ke
    Chen, Yucheng
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (01): : 245 - 246
  • [40] Exagerration of interferon-alpha pathway and BAFF production in patients with Sjogren's syndrome after Anti-TNF treatment.
    Mavragani, Clio P.
    Niewold, Timothy B.
    Moutsopoulos, Niki M.
    Hua, Jing
    Stanley, Pillemer
    Wahl, Sharon
    Crow, Mary K.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S312 - S313
12345